Page last updated: 2024-09-02

tryptoline and ER-Negative PR-Negative HER2-Negative Breast Cancer

tryptoline has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, C; Chen, H; Cheng, D; Jiang, X; Liu, R; Nie, Z; Wang, C; Wang, D; Wei, Z; Wu, Y; Ye, J	1

Other Studies

1 other study(ies) available for tryptoline and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Pyrrolo [3,4- Aging, 2020, 05-23, Volume: 12, Issue:10 Topics: Amines; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbolines; Cell Line, Tumor; Female; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Quinolines; Triple Negative Breast Neoplasms; X-Linked Inhibitor of Apoptosis Protein	2020

Article

Year

Pyrrolo [3,4-

Aging, 2020, 05-23, Volume: 12, Issue:10

Topics: Amines; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbolines; Cell Line, Tumor; Female; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Quinolines; Triple Negative Breast Neoplasms; X-Linked Inhibitor of Apoptosis Protein

2020